Studies a implanted pressure sensor in people with heart failure
Studies whether a pulmonary artery pressure sensor guides heart failure care in adults.
Plain-language title generated from the registry record
Registry title: CardioMEMS HF System Coverage With Evidence Development Study
Key facts
- Where
- Pleasanton, United StatesSee the site
Where in United States
- AbbottPleasanton, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Abbott Medical Devices
- Trial code
- NCT06779552
- Record updated
- 3 April 2026
- Original description
The purpose of the CardioMEMS CED Study is to determine if pulmonary artery (PA) pressure-guided heart failure management using the CardioMEMS™ HF System improves long-term health outcomes in heart failure (HF) patients in the real-world setting.Read full original descriptionShow less
CardioMEMS HF System Coverage With Evidence Development Study
The purpose of the CardioMEMS CED Study is to determine if pulmonary artery (PA) pressure-guided heart failure management using the CardioMEMS™ HF System improves long-term health outcomes in heart failure (HF) patients in the real-world setting.
Inclusion: Subject implanted with a CardioMEMS pressure sensor (treatment arm only); Subject >=18 years of age at time of implant; Subject has a history of acute decompensated HF or HF-related congestion defined by at least one of the following qualifying event types: HF hospitalization, elevated BNP/NT-proBNP.
Exclusion: Subject received prior PA pressure sensor implant (control arm only); Subject has history of heart transplant or durable mechanical circulatory device; Subject hospitalized with cardiogenic shock or sepsis.